FRANCISCO
VANACLOCHA SEBASTIÁN
Investigador en el període 2009-2016
![Foto de FRANCISCO](/img/nophoto.png)
![Foto de Oregon Medical Research Center](/img/noimage_org.png)
Oregon Medical Research Center
Portland, Estados UnidosPublicacions en col·laboració amb investigadors/es de Oregon Medical Research Center (3)
2017
-
Secukinumab demonstrates greater sustained improvements in daily activities and personal relationships than ustekinumab in patients with moderate-to-severe plaque psoriasis: 52-week results from the CLEAR study
Journal of the European Academy of Dermatology and Venereology, Vol. 31, Núm. 10, pp. 1693-1699
-
Secukinumab is superior to ustekinumab in clearing skin of subjects with moderate-to-severe plaque psoriasis up to 1 year: Results from the CLEAR study
Journal of the American Academy of Dermatology, Vol. 76, Núm. 1, pp. 60-69.e9
2015
-
Secukinumab is superior to ustekinumab in clearing skin of subjects with moderate to severe plaque psoriasis: CLEAR, a randomized controlled trial
Journal of the American Academy of Dermatology, Vol. 73, Núm. 3, pp. 400-409